Palvella Therapeutics stockPVLA
Palvella Therapeutics trades at $156.85, 5.9% below its 52-week high (Nov 5, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +49.9% year to date, +107.1% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for PVLA — after you log in
Open the terminalFrequently asked questions about Palvella Therapeutics
What is the Palvella Therapeutics stock price?
At the close on Nov 5, 2026: $156.85 (−3.35% on the day). 52-week high: $166.73 on Nov 5, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Palvella Therapeutics report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed −65% year over year, revenue 0%.
Does Palvella Therapeutics pay dividends?
No, Palvella Therapeutics does not pay dividends.
Where does Palvella Therapeutics trade and how to buy it?
Ticker PVLA, exchange Nasdaq. You can buy it through a broker with access to US exchanges.
Should I buy Palvella Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for PVLA are in the terminal after you log in.